- Home
- DHAI vs EVGN Comparison
DHAI vs EVGN Comparison
Compare DHAI & EVGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DHAI
- EVGN
- Stock Information
- Founded
- DHAI 2007
- EVGN 1999
- Country
- DHAI United States
- EVGN Israel
- Employees
- DHAI N/A
- EVGN N/A
- Industry
- DHAI
- EVGN Agricultural Chemicals
- Sector
- DHAI
- EVGN Industrials
- Exchange
- DHAI NYSE
- EVGN Nasdaq
- Market Cap
- DHAI 11.6M
- EVGN 11.9M
- IPO Year
- DHAI N/A
- EVGN N/A
- Fundamental
- Price
- DHAI $0.27
- EVGN $1.31
- Analyst Decision
- DHAI
- EVGN Strong Buy
- Analyst Count
- DHAI 0
- EVGN 1
- Target Price
- DHAI N/A
- EVGN $3.50
- AVG Volume (30 Days)
- DHAI 2.6M
- EVGN 110.4K
- Earning Date
- DHAI 08-18-2025
- EVGN 08-21-2025
- Dividend Yield
- DHAI N/A
- EVGN N/A
- EPS Growth
- DHAI N/A
- EVGN N/A
- EPS
- DHAI N/A
- EVGN N/A
- Revenue
- DHAI $69,573,000.00
- EVGN $6,765,000.00
- Revenue This Year
- DHAI N/A
- EVGN N/A
- Revenue Next Year
- DHAI N/A
- EVGN $113.18
- P/E Ratio
- DHAI N/A
- EVGN N/A
- Revenue Growth
- DHAI 5.40
- EVGN N/A
- 52 Week Low
- DHAI $0.12
- EVGN $0.95
- 52 Week High
- DHAI $3.25
- EVGN $5.70
- Technical
- Relative Strength Index (RSI)
- DHAI 53.70
- EVGN 48.24
- Support Level
- DHAI $0.24
- EVGN $1.32
- Resistance Level
- DHAI $0.31
- EVGN $1.38
- Average True Range (ATR)
- DHAI 0.03
- EVGN 0.07
- MACD
- DHAI 0.00
- EVGN -0.00
- Stochastic Oscillator
- DHAI 50.63
- EVGN 26.92
About DHAI DIH HOLDINGS US INC
DIH Holding US Inc is a provider of robotic devices used in physical rehabilitation, which incorporate visual stimulation in an interactive manner to enable clinical research and intensive functional rehabilitation and training in patients with walking impairments, reduced balance and/or impaired arm and hand functions. Its products Armeo Power, Armeo Spring, Armeo Spring Pro, etc.
About EVGN Evogene Ltd
Evogene Ltd is a computational biology company targeting to revolutionize product development for life-science based industries, including human health, agriculture, and industrial applications. The company established its technology, the Computational Predictive Biology (CPB) platform. The CPB platform is designed to computationally discover and develop life-science products based on microbes, small molecules, and genetic elements as the core components for such products. It holds several subsidiaries utilizing the CPB platform for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits, and ag-solutions for castor oil production. It generates maximum revenue from the Agriculture segment, followed by Industry.